These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33014113)

  • 1. Curcumin Regulates ERCC1 Expression and Enhances Oxaliplatin Sensitivity in Resistant Colorectal Cancer Cells through Its Effects on miR-409-3p.
    Han W; Yin H; Ma H; Wang Y; Kong D; Fan Z
    Evid Based Complement Alternat Med; 2020; 2020():8394574. PubMed ID: 33014113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [MiR-145 inhibits drug resistance to Oxaliplatin in colorectal cancer cells through regulating G protein coupled receptor 98].
    Fu Q; Cheng J; Zhang J; Zhang Y; Chen X; Xie J; Luo S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):566-570. PubMed ID: 28534337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-200b-3p mitigates oxaliplatin resistance via targeting TUBB3 in colorectal cancer.
    Wu YZ; Lin HY; Zhang Y; Chen WF
    J Gene Med; 2020 Jul; 22(7):e3178. PubMed ID: 32092782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zuo Jin Wan Reverses the Resistance of Colorectal Cancer to Oxaliplatin by Regulating the MALAT1/miR-200s/JNK Signaling Pathway.
    Wei Z; Zhou J; Yu H; Pu Y; Cheng Y; Zhang Y; Ji Q; Zhu H
    Evid Based Complement Alternat Med; 2022; 2022():3032407. PubMed ID: 36248422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of oxaliplatin sensitivity in human colorectal cancer by hypericin mediated photodynamic therapy via ROS-related mechanism.
    Lin S; Lei K; Du W; Yang L; Shi H; Gao Y; Yin P; Liang X; Liu J
    Int J Biochem Cell Biol; 2016 Feb; 71():24-34. PubMed ID: 26673998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of KLK11 reverses oxaliplatin resistance by inhibiting proliferation and activating apoptosis via suppressing the PI3K/AKT signal pathway in colorectal cancer cell.
    Zhang Y; Xu Z; Sun Y; Chi P; Lu X
    Onco Targets Ther; 2018; 11():809-821. PubMed ID: 29497313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-33a-5p in small extracellular vesicles as non-invasive biomarker for oxaliplatin sensitivity in human colorectal cancer cells.
    Tanaka S; Hosokawa M; Miyamoto T; Nakagawa A; Haruna M; Ueda K; Iwakawa S; Ogawara KI
    Biochem Biophys Rep; 2021 Jul; 26():100996. PubMed ID: 33898768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linc01559 Served as a Potential Oncogene and Promoted Resistance of Hepatocellular Carcinoma to Oxaliplatin by Directly Sponging miR-6783-3p.
    Dong S; Fu Y; Yang K; Zhang X; Miao R; Long Y; Liu C
    Anticancer Agents Med Chem; 2021; 21(2):278-286. PubMed ID: 32698745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal effect of ginsenoside Rh2 on oxaliplatin-resistant colon cancer cells and its mechanism.
    Ma J; Gao G; Lu H; Fang D; Li L; Wei G; Chen A; Yang Y; Zhang H; Huo J
    Exp Ther Med; 2019 Jul; 18(1):630-636. PubMed ID: 31258699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
    Tozawa K; Oshima T; Kobayashi T; Yamamoto N; Hayashi C; Matsumoto T; Miwa H
    Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.
    Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y
    Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-153-5p promotes sensibility of colorectal cancer cells to oxaliplatin via targeting Bcl-2-mediated autophagy pathway.
    He Y; Zhang L; Tan F; Wang LF; Liu DH; Wang RJ; Yin XZ
    Biosci Biotechnol Biochem; 2020 Aug; 84(8):1645-1651. PubMed ID: 32380907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137.
    Liang J; Tian XF; Yang W
    World J Gastroenterol; 2020 Apr; 26(13):1474-1489. PubMed ID: 32308348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression.
    Zhou H; Lin C; Zhang Y; Zhang X; Zhang C; Zhang P; Xie X; Ren Z
    Cell Prolif; 2017 Jun; 50(3):. PubMed ID: 28217977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of medicated serum prepared with Chinese herbal medicine Changweiqing on pharmacokinetics of oxaliplatin in colon cancer cells].
    Zhang Y; Sun XW; Xu JH; Lu H; Fan ZZ; Sun J; Zhang XX
    Zhong Xi Yi Jie He Xue Bao; 2012 Aug; 10(8):901-10. PubMed ID: 22883407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of ADAM17 inhibits cell proliferation and increases oxaliplatin sensitivity in HCT-8 colorectal cancer through EGFR-PI3K-AKT activation.
    Zhang Q; Wang C; Han X; Yang G; Ge Z; Zhang G
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2333-2339. PubMed ID: 29964008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gfi-1 modulates HMGB1-Mediated autophagy to overcome oxaliplatin resistance in colorectal cancer.
    Liu W; Zhang Z; Zhang L; Jiang X; Chen C; Wu X; Zhao Q
    Heliyon; 2024 May; 10(9):e29859. PubMed ID: 38694127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy.
    Tsubaki M; Takeda T; Matsuda T; Kishimoto K; Takefuji H; Taniwaki Y; Ueda M; Hoshida T; Tanabe K; Nishida S
    Cancer Cell Int; 2023 Apr; 23(1):73. PubMed ID: 37069612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis and suppression of ERCC1 expression by the potent amonafide analogue 8-c in human colorectal carcinoma cells.
    Wang Z; Liang X; Cheng Z; Xu Y; Yin P; Zhu H; Li Q; Qian X; Liu J
    Anticancer Drugs; 2013 Apr; 24(4):355-65. PubMed ID: 23426174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of YEATS4 by miR-218 sensitizes colorectal cancer cells to L-OHP-induced cell apoptosis by inhibiting cytoprotective autophagy.
    Fu Q; Cheng J; Zhang J; Zhang Y; Chen X; Xie J; Luo S
    Oncol Rep; 2016 Dec; 36(6):3682-3690. PubMed ID: 27779719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.